Therapeutic Advances in Hematology

译名:血液病学治疗进展

SCIEJCR Q2

1-3

2026

影响因子区间

平台估算

投稿周期

45%

2025

中国作者发文占比

费用说明

收费

期刊简介:Therapeutic Advances in Hematology delivers the highest quality peer-reviewed articles, reviews, and scholarly comment on pioneering efforts and innovative studies across all areas of hematology. The journal has a strong clinical and pharmacological focus and is aimed at clinicians and researchers in hematology, providing a forum in print and online for publishing the highest quality articles in this area.

【译文】血液学治疗进展期刊提供最高质量的同行评审文章、评论和学术评论,涵盖血液学所有领域的开创性努力和创新研究。该期刊具有强烈的临床和药理学重点,面向血液学临床医生和研究人员,旨在为该领域的最高质量文章提供一个印刷和在线发表的平台。

出版社
SAGE Publishing
语言
English
学科
医学
ISSN
2040-6207
eISSN
2040-6215
出版频率
年刊
创刊年份
2004
投稿网址
https://us.sagepub.com/en-us/nam/journal/therapeutic-advances-hematology#submission-guidelines
最近更新
2026-04-02 18:16:40
Therapeutic Advances in Hematology

指标当前值近三年趋势
JCR分区Q2
暂无
影响因子区间1-3
暂无